Tongue hyperpigmentation during hepatitis C treatment.
作者信息
Bachmeyer Claude, Pellen Jean-Charles
机构信息
Department of Internal Medicine, Tenon Hospital, Paris, France.
出版信息
CMAJ. 2012 Sep 18;184(13):1498. doi: 10.1503/cmaj.111985. Epub 2012 Mar 26.
Abstract
摘要
相似文献
1
Tongue hyperpigmentation during hepatitis C treatment.
CMAJ. 2012 Sep 18;184(13):1498. doi: 10.1503/cmaj.111985. Epub 2012 Mar 26.
2
Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C.
J Am Acad Dermatol. 2010 Jan;62(1):164-165. doi: 10.1016/j.jaad.2009.03.021.
3
[Information for patients. Treatment of acute hepatitis C].
Rev Esp Enferm Dig. 2011 Oct;103(10):549. doi: 10.4321/s1130-01082011001000010.
4
Lingual hyperpigmentation with pegylated interferon and ribavirin therapy in patients with chronic hepatitis C.
Indian J Gastroenterol. 2006 Nov-Dec;25(6):324.
5
"Hepatitis C (HCV) treatment is not a "one size fits all".
W V Med J. 2012 Mar-Apr;108(2):20, 22-4.
6
Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy.
Am J Gastroenterol. 2007 Jun;102(6):1334-5. doi: 10.1111/j.1572-0241.2007.01162.x.
7
Tongue hyperpigmentation during PEG-interferon-alfa/ribavirin therapy in a non-Caucasian patient with chronic hepatitis C: a case report and review of the literature.
Int J Dermatol. 2013 May;52(5):643-4. doi: 10.1111/j.1365-4632.2011.04921.x. Epub 2012 Oct 9.
8
What caused this lingual hyperpigmentation in a patient with chronic hepatitis C?
Liver Int. 2010 Mar;30(3):416. doi: 10.1111/j.1478-3231.2009.02025.x. Epub 2009 Apr 28.
9
Summaries for patients. Pegylated interferon with or without ribavirin for patients with hepatitis C receiving hemodialysis.
Ann Intern Med. 2013 Dec 3;159(11):I-14. doi: 10.7326/0003-4819-159-11-201312030-00001.
10
[Lingual hyperpigmentation in a patient with chronic infection].
Enferm Infecc Microbiol Clin. 2013 Apr;31(4):264-5. doi: 10.1016/j.eimc.2012.10.012. Epub 2012 Dec 20.
本文引用的文献
1
Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C.
J Am Acad Dermatol. 2010 Jan;62(1):164-165. doi: 10.1016/j.jaad.2009.03.021.
2
Tongue and skin hyperpigmentation during PEG-interferon-alpha/ribavirin therapy in dark-skinned non-Caucasian patients with chronic hepatitis C.
Am J Gastroenterol. 2006 Jan;101(1):197-8. doi: 10.1111/j.1572-0241.2005.00323.x.
3
Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection.
Br J Dermatol. 2003 Aug;149(2):390-4. doi: 10.1046/j.1365-2133.2003.05422.x.
Zotero 插件